U.S. Water wins $7.58 million judgment against Novozymes for patent infringement

In Minnesota, U.S. Water announced that last week a federal jury in the Western District of Wisconsin delivered a unanimous verdict in favor of U.S. Water in its lawsuit against Novozymes A/S and Novozymes North America, Inc. The jury found that Novozymes’s sale of Phytaflow® to its customers caused infringement of the U.S. Water patents asserted in that case, U.S. Patent Nos. 8,415,137 and 8,609,399, relating to U.S. Water’s pHytOUT® deposit control technology and that these patents are valid. The jury awarded U.S. Water $7.58 million in past damages for Novozymes’s infringement.